Collateral for a security interest recorded Apr 30, 2024 (Orbimed Royalty & Credit Opportunities IV, LP).
Term ends Nov 30, 2034 · High confidence
20-year base term ends Apr 23, 2034
Held by Trisalus Life Sciences, Inc.
Filed Sep 14, 2021 as application 17/474,633 · Granted Dec 23, 2025
Base term plus 221 days of patent term adjustment (USPTO delay)
Today
2014
2034
Clock starts
Apr 23, 2014
Apr 23, 2014
Term ends
Nov 30, 2034
Nov 30, 2034
Granted
Dec 23, 2025
Dec 23, 2025
base term
patent term adjustment
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
221
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
0 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
7
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 221 days past its 20-year base term on prosecution delay. 0 of 2 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Apr 23, 2014, when application 14/259,293, the earliest non-provisional in its chain, was filed (this one was filed Sep 14, 2021) | Apr 23, 2034 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +221 days, USPTO patent term adjustment record | Nov 30, 2034 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 2 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Nov 30, 2034 | High confidence |
This family
| US 9,770,319 | In force Oct 2035 | Oct 2035 |
| US 9,889,031 | In force Sep 2036 | Sep 2036 |
| US 9,968,740 | In force Oct 2035 | Oct 2035 |
| US 11,135,361 | In force Feb 2035 | Feb 2035 |
| US 12,138,424 | In force Nov 2035 | Nov 2035 |
| US 12,502,479 | this patent Nov 2034 | Nov 2034 |
| Application 19/429,621 | Pending not computed | not computed |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Sep 15, 2021 Reel 57597, frame 748 | Pinchuk, Bryan; Chomas, James E. | Surefire Medical, Inc. | Assignment of Assignor's Interest |
| Sep 30, 2021 Reel 57693, frame 506 | Surefire Medical, Inc. | Trisalus Life Sciences, Inc. | Change of Name |
| Apr 30, 2024 Reel 67274, frame 733 | Trisalus Life Sciences, Inc. | Orbimed Royalty & Credit Opportunities IV, LP | Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Nov 2034
Term ends Nov 30, 2034. Maintenance fees still fall due before then
Note
The 221 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
0
later US patents cite this one
Fewer than half of the utility patents granted in 2025 in our data have been cited yet, so we show the count and do not rank on it.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.